— Know what they know.
Not Investment Advice

AMPH NASDAQ

Amphastar Pharmaceuticals, Inc.
1W: +5.0% 1M: -13.5% 3M: -36.4% YTD: -31.4% 1Y: -27.6% 3Y: -57.7% 5Y: -9.1%
$18.41
+0.25 (+1.38%)
 
Weekly Expected Move ±12.5%
$13 $15 $17 $19 $21
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Strong Sell · Power 30 · $811.8M mcap · 33M float · 1.89% daily turnover · Short 52% of daily vol

Cash Flow Trends

Operating Cash Flow
$156M -26.8% ▼
5Y CAGR: +22.2%
Capital Expenditures
$35M +15.0% ▲
5Y CAGR: +0.6%
Free Cash Flow
$121M -29.7% ▼
5Y CAGR: +38.9%
Dividends Paid
$0 +0.0% ▲
Buybacks
$76M +11.6% ▲
Net Change in Cash
$19M +153.9% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$63M$91M$138M$160M$98M
Depreciation & Amort.$27M$29M$42M$57M$63M
Stock-Based Comp.$19M$18M$20M$24M$27M
Change in Working Capital-$2M-$32M-$24M-$15M-$66M
Other Non-Cash Items-$13M-$878K$22M$5M$6M
Operating Cash Flow$98M$89M$184M$213M$156M
— Investing Activities —
Capital Expenditures-$27M-$24M-$38M-$41M-$35M
Acquisitions (Net)$0$421K-$506M-$129M$0
Investment Purchases-$17M-$36M-$145M-$77M-$119M
Investment Sales$19M$28M$39M$126M$90M
Other Investing-$3M-$1M$1M-$4M-$7M
Investing Cash Flow-$29M-$33M-$649M-$125M-$70M
— Financing Activities —
Net Debt Issuance$32M-$2M$526M$10M$5M
Stock Repurchased-$29M-$40M-$58M-$85M-$76M
Dividends Paid$0$0$0$0$0
Other Financing-$40M$15M-$14M-$6M$0
Financing Cash Flow-$37M-$26M$454M-$81M-$67M
Net Change in Cash$32M$30M-$12M$7M$19M
Cash End of Period$127M$156M$145M$152M$170M
Free Cash Flow$71M$65M$145M$172M$121M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms